Coverage has been significantly strengthened across key therapeutic categories, including anti-tubercular, anti-diabetic and anti-cancer medicines, as well as iron supplements, thereby ensuring more comprehensive standardisation of medicines used under various National Health Programmes
Once finalized, cough syrups will no longer be available for over-the-counter sale
The company announced that it has been granted patent covering “Substituted Ethylamine Fused Heterocyclic Mescaline Derivatives.”
Transcenta will grant EirGenix a non-exclusive license to its Highly Intensified Continuous Bioprocessing (HiCB) platform
The partnership also sets the stage for broader collaboration on rare disease treatments
CX-5461 is “the world's first and most advanced G-quadruplex (G4) stabilizer in development
The cancellation underscores the regulator’s strict stance against misleading cosmetic claims
BBIL will guarantee production and supply of MTBVAC to more than 70 countries across Africa and Southeast Asia
The therapy targets the LRRC15 protein and is designed for enhanced tumor penetration and differentiated anti-tumor activity in solid tumors with the highest unmet needs.
Subscribe To Our Newsletter & Stay Updated
